SEC Form 4 research
| Issuer | Moleculin Biotech, Inc. |
|---|---|
| Tickers | MBRX |
| Reporting owners | 11 |
| Officers and directors | 5 |
| Last public filing | 2026-10-17 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-16 | 2026-10-15 | PICKER DONALD H | A | 250,000 | Not reported | Not reported |
| 2026-10-16 | 2026-10-15 | KLEMP WALTER V | A | 415,000 | Not reported | Not reported |
| 2026-10-16 | 2026-10-15 | KLEMP WALTER V | A | 415,000 | Not reported | Not reported |
| 2026-10-16 | 2026-10-15 | Foster Jonathan P. | A | 260,000 | Not reported | Not reported |
| 2026-10-16 | 2026-10-15 | Foster Jonathan P. | A | 260,000 | Not reported | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.